SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 30th, 2020 • Immune Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 30th, 2020 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 4, 2020, by and between IMMUNE THERAPEUTICS, INC., a Florida corporation, with its address at 2431 Aloma Ave #124, Winter Park, FL 32792 (the “Company”), and GENEVA ROTH REMARK HOLDINGS, INC., a New York corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021 (the “Buyer”).